Jordan’s pharmaceutical exports rise 3.8% in H1 ’24

Jordan’s pharmaceutical industries and medical supplies sector defied regional difficulties by achieving a 3.8 per cent export increase in the first half of 2024 compared to the same period in 2023.

This positive performance is highlighted in a statement by Fadi Atrash, the sector’s representative at the Jordan Chamber of Industry (JCI), quoted by Jordan News Agency (Petra).

Despite “exceptional circumstances” in the region, including the Israeli aggression against Gaza and disruptions to Red Sea trade movement, the sector’s exports climbed to JD370 million ($520 million) during the first half of 2024. This marks a notable increase from JD356 million ($503 million) during the same period in 2023.

Atrash emphasised the significance of these figures, compiled by Jordan’s three chambers of industry in Amman, Irbid, and Zarqa. The data reveals that the pharmaceutical and medical supplies sector ranks sixth in terms of export value and positive growth among Jordanian industries.

He observed that some factories in the sector have expanded by introducing new production lines for animal vaccines, vitamins, and innovative pharmaceuticals like intravenous injections and sprays.

Atrash mentioned that the pharmaceutical industry and medical supplies sector consists of 151 establishments with a total capital of JD341 million.

Additionally, there are 15 Jordanian factories located outside the Kingdom in countries such as Saudi Arabia, Algeria, Egypt, Morocco, and Sudan.

Attribution: WAM